| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 p53-Mdm2--the affair that never ends Alarcon-Vargas D; Ronai ZCarcinogenesis  2002[Apr]; 23 (4): 541-7The p53-Mdm2 paradigm represents the best-studied relationship between a tumor  suppressor gene which functions as a transcription factor and an oncogene, which  functions primarily as an E3 protein ligase. The intimate relationship between  these two partners has expanded to include almost every cellular biological  system - from development, to growth control and programmed cell death. The  affair between Mdm2 and p53 is closely controlled by a complex array of  post-translational modifications, which in turn dictates the stability and  activity of p53 and Mdm2. Functional diversity depends on the association with a  large subset of partner proteins, which dictates the type of activity and  corresponding selectivity. Here we summarize the current understanding of  post-translational modifications and their effect on conformation-based  functional relationship between Mdm2 and p53, as it pertains to their diverse  cellular biological functions.|*Nuclear Proteins[MESH]|Humans[MESH]|Neoplasms/metabolism[MESH]|Phosphorylation[MESH]|Protein Conformation[MESH]|Protein Processing, Post-Translational[MESH]|Proto-Oncogene Proteins c-mdm2[MESH]|Proto-Oncogene Proteins/metabolism/*physiology[MESH]|Tumor Suppressor Protein p53/metabolism/*physiology[MESH]
 |